iollo

iollo, headquartered in San Francisco, CA, with additional operations in Zürich, ZH, and a fully remote team, operates within the healthcare industry, specifically focusing on metabolomics. As part of the Y-Combinator S22 batch, iollo provides advanced at-home tests that measure over 500 biomarkers in blood samples, using these for dietary, behavioral, and therapeutic interventions. The company employs cutting-edge mass spectrometry technology to quantify metabolites and utilizes AI and machine learning to offer personalized health insights and recommendations. These recommendations are grounded in scientific research known to impact health positively. iollo’s services include a comprehensive analysis of various health aspects such as gut microbiome, aging, immune response, and more, allowing for longitudinal metabolic monitoring. Additionally, iollo fosters a community by enabling users to connect and share insights in public or semi-public spaces, and is actively involved in research partnerships to further scientific knowledge.